Animal Growth Promoters and Performance Enhancers Market by Type (Antibiotic and Non-antibiotic (Hormones, Acidifiers, Feed Enzymes, Probiotics & Prebiotics, Phytogenic)), Animal Type (Poultry, Porcine, Livestock, Aquaculture) - Global Forecast to 2026

Publisher Name :
Date: 29-Oct-2021
No. of pages: 245
Inquire Before Buying

“The global animal growth promoters and performance enhancers market is projected to grow at a CAGR of 5.7%”

The global animal growth promoters and performance enhancers market is projected to reach USD 21.4 billion by 2026 from USD 16.2 billion in 2021, at a CAGR of 5.7%. Animal health products, including growth promoters and performance enhancers, are types of drugs and chemicals used for animal growth. These enhancers help to digest food more effectively and enable animals to grow faster, which, in turn, help to improve productivity. Growth in the animal growth promoters and performance enhancers market is majorly driven by the rising demand for animal consumption and consumption of livestock-based products, rising global demand for naturally produced growth promoters, and rising animal epidemics and climate change. However, a ban on antibiotics in different nations and stringent regulations restricting the use of antibiotics and hormones for growth promotion in animals are expected to restrain the growth of the animal growth promoters and performance enhancers market during the forecast period.

“The non-antibiotic growth promoters and performance enhancers segment is expected to account for the largest share of the animal growth promoters and performance enhancers market”

The non-antibiotic growth promoters and performance enhancers segment accounted for the largest share of the animal growth promoters and performance enhancers market in 2020. The large share of this segment can be attributed to the economic benefits of these products, the wide range of substances with applications in different production animals, environmental sustainability, and the increased number of regulations on antibiotics and hormones.

“Poultry segment is expected to account for the largest share of the animal growth promoters and performance enhancers market”

Based on animal type, the poultry segment accounted for the largest share of the global animal growth promoters and performance enhancers market. The large market share of this segment can be attributed to the increasing demand for poultry meat and eggs, rising novel diet approaches, and increasing antibiotic phase-outs resulting in the development of alternatives.

“Asia Pacific to dominate the animal growth promoters and performance enhancers market during the forecast period”

Asia Pacific region accounted for the largest market share, followed by North America with a share in 2020. The large share of the Asia Pacific region can be attributed to the strong animal products industry in this region, huge population generating greater domestic meat demand, comparatively relaxed regulatory scenario, and government efforts to encourage animal producers.

A breakdown of the primary participants for the animal growth promoters and performance enhancers market referred to for this report is provided below:


  • By Company Type: Tier 1–40%, Tier 2–30%, and Tier 3–30%

  • By Designation: C-level–27%, Director Level–18%, and Others–55%

  • By Region: North America–50%, Europe–20%, Asia Pacific–15%, RoW- 15%


The prominent players in the animal growth promoters and performance enhancers market include Cargill, Incorporated (US), Royal DSM N.V. (Netherlands), Elanco Animal Health Incorporated (US), Boehringer Ingelheim Group (Germany), Merck & Co., Inc (US), Alltech Corporation (US), Archer-Daniels-Midland Company (ADM) (US), Vetoquinol S.A. (France), Bupo Animal Health Pty Ltd (South Africa), Novus International, Inc. (US), Associated British Foods plc (UK), Erber AG (Austria), Phibro Animal Health Corporation (US), Kemin Industries, Inc. (US), Zoetis Inc. (US), Nutreco N.V. (Netherlands), Novozymes A/S (Denmark), BASF SE (Germany), Evonik Industries AG (Germany), Bluestar Adisseo Company (China), Land O’Lakes, Inc. (US), Chr. Hansen (Denmark), Biomin Holding GmbH (Austria), Guangdong VTR Bio-Tech Co., Ltd. (China), and Lallemand Inc. (Canada).

Research Coverage:

The report analyzes the market for various animal growth promoters and performance enhancers and their adoption pattern. It aims at estimating the market size and future growth potential of the global animal growth promoters and performance enhancers market and different segments such as type, animal type and region. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product & service offerings, and recent developments.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening their market presence.

This report provides insights on the following pointers:


  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the global animal growth promoters and performance enhancers market

  • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product or service launches in the global animal growth promoters and performance enhancers market

  • Market Development: Comprehensive information on the lucrative emerging regions by type, animal type, and region

  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the global animal growth promoters and performance enhancers market.

  • Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis, and products & services of leading players in the global animal growth promoters and performance enhancers market.

Animal Growth Promoters and Performance Enhancers Market by Type (Antibiotic and Non-antibiotic (Hormones, Acidifiers, Feed Enzymes, Probiotics & Prebiotics, Phytogenic)), Animal Type (Poultry, Porcine, Livestock, Aquaculture) - Global Forecast to 2026

Table of Contents

1 Introduction
1.1 Objective of the study
1.2 Market Definition
1.2.1 Inclusion and Exclusion
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered in the Study
1.4 Currency
1.5 Stakeholders
1.6 Summary of Changes

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key data from secondary sources
2.1.2 Primary Data
2.1.2.1 Key data from primary sources
2.1.2.2 Key Industry Insight
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Market share Estimation
2.5 Assumptions for the study
2.6 Limitations
2.7 Risk Assessment
2.8 Assessment of the impact of COVID-19 on the economic scenario in the Animal Growth Promoters and Performance Enhancers market

3 Executive Summary

4 Premium Insights
4.1 Animal Growth Promoters and Performance Enhancers Market Overview
4.2 Geographic Analysis: Animal Growth Promoters and Performance Enhancers Market
4.3 Animal Growth Promoters and Performance Enhancers Market: Geographic growth opportunities
4.4 Reagonal Mix:Animal Growth Promoters and Performance Enhancers Market (2019–2026)

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increase in demand and consumption of livestock-based products
5.2.1.2 Research into alternatives to antibiotics and hormones and increasing demand for non-antibiotic growth promoters
5.2.1.3 Rise in the global demand for naturally produced growth promotors
5.2.1.4 Rise in awareness about growth promotors
5.2.1.5 Rise in animal epidemics and climate changes
5.2.2 Restraints
5.2.2.1 Ban on antibiotics in different nations
5.2.2.2 Stringent regulations restricting the use of antibiotics and hormones for growth promotion in animals
5.2.3 Opportunities
5.2.3.1 Focus on increasing environment sustainabilit
5.2.4 Challenges
5.2.4.1 Increasing global feed tonnage and high feed costs leading to the adoption of conventional feeding systems
5.2.4.2 Growing threat of disease transmission to and from agricultural animals

6 Industry Insights
6.1 Technology Analysis
6.2 Industry Trends
6.3 Pricing Analysis
6.4 Value Chain Analysis
6.5 Ecosystem Mapping
6.6 Supply Chain Analysis
6.7 Porter's Five Forces Analysis
6.8 Regulatory Analysis
6.9 Patent Analysis
6.9.1 Patent Publication trends for Animal Growth Promoters and Performance Enhancers Market
6.10 Trade Analysis
6.11 Impact of COVID-19 on the Endoscopy equipment Market

7 Animal Growth Promoters and Performance Enhancers Market, by Type
7.1 Introduction
7.2 Non-Antibiotic Growth Promoters and Performance Enhancers
7.2.1 Prebiotics & Probiotics
7.2.2 Acidifiers
7.2.3 Phytogenic
7.2.4 Feed Enzymes
7.2.5 Hormones
7.2.6 Other Non-Antibiotic Growth Promoters and Performance Enhancers
7.3 Antibiotic Growth Promoters

8 Animal Growth Promoters and Performance Enhancers t Market, by Animal Type
8.1 Introduction
8.2 Poultry
8.3 Swine
8.4 Livestock
8.5 Aquatic Animals
8.6 Other Animals

9 Animal Growth Promoters and Performance Enhancers Market, by Region
9.1 Introduction
9.2 Asia-Pacific
9.2.1 Japan
9.2.2 China
9.2.3 India
9.2.4 Australia
9.2.5 ROAPAC
9.3 North America
9.3.1 US
9.3.2 Canada
9.4 Europe
9.4.1 UK
9.4.2 Germany
9.4.3 Switzerland
9.4.4 Russsia
9.4.5 ROE
9.5 Latin America
9.5.1 Brazil
9.5.2 Rest Latin America
9.6 Middle East
9.7 Africa

10 Competitive Landscape
10.1 Introduction
10.2 Revenue Analysis of Key Market Players
10.3 Market Share Analysis
10.4 Competitive Scenario
10.4.1 Product Launch
10.4.2 Deals
10.4.3 Other Development
10.5 Competitive Benchmarking
10.6 Company Evaluation matrix
10.6.1 Stars
10.6.2 Emerging leaders
10.6.3 Pervasive players
10.6.4 Emerging companies
10.7 Company Leadership mapping (SME/START-UPS)
10.7.1 Progressive companies
10.7.2 Starting Blocks
10.7.3 Responsive Companies
10.7.4 Dynamic companies
10.8 R&D Expanditure assessment of key players
10.9 Geographical revenue assessment of key players

11 Company Profiles
11.1 Key Players
11.1.1 Cargill, Inc.
11.1.2 Royal DSM N.V.
11.1.3 Elanco Animal Health Inc
11.1.4 Boehringer Ingelheim International GmbH
11.1.5 Merck & Co., Inc
11.1.6 Alltech, Inc.
11.1.7 Archer-Daniels-Midland Company (ADM)
11.1.8 Vetoquinol
11.1.9 Bupo Animal Health
11.1.10 Novus International, Inc.
11.2 Other Players
11.2.1 Associated British Foods Plc
11.2.2 ERBER AG
11.2.3 Phibro Animal Health Corporation
11.2.4 Kemin Industries Inc.
11.2.5 Zoetis, Inc.
11.2.6 Nutreco N.V. (A Wholly Owned Subsidiary of SHV Group)
11.2.7 Novozymes A/S
11.2.8 BASF SE
11.2.9 Evonik Industries Ag
11.2.10 Bluestar Adisseo Company
11.2.11 Land O’lakes, Inc.
11.2.12 CHR. HANSEN
11.2.13 Biomin Holding GMBH
11.2.14 Guangdong VTR Bio-Tech Co., Ltd.
11.2.15 Lallemand Inc.

12 Appendix
12.1 Discussion Guide
12.2 Knowledge store: marketsandmarkets’ subscription portal
12.3 Available Customizations
12.4 Related Reports
12.5 Author Details

  • Global Classical Swine Fever Vaccines Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 100
    It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of The genus Pestivirus of The family Flaviviridae, and is closely related to The viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV). The global Classical Swine Fever Vaccines market was valued at US$ 154.7 million in 2023 and is anticipa......
  • Global Tylosin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global Tylosin market size was valued at US$ 674.4 million in 2023. With growing demand in downstream market, the Tylosin is forecast to a readjusted size of US$ 909 million by 2030 with a CAGR of 4.4% during review period. The research report highlights the growth potential of the global Tylosin market. Tylosin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chai......
  • Global Animal Parasiticides Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106
    According to our LPI (LP Information) latest study, the global Animal Parasiticides market size was valued at US$ 6898.6 million in 2023. With growing demand in downstream market, the Animal Parasiticides is forecast to a readjusted size of US$ 9363.4 million by 2030 with a CAGR of 4.5% during review period. The research report highlights the growth potential of the global Animal Parasiticides market. Animal Parasiticides are expected to show stable growth in the future market. However, ......
  • Global Newcastle Disease Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114
    According to our LPI (LP Information) latest study, the global Newcastle Disease Vaccine market size was valued at US$ 308 million in 2023. With growing demand in downstream market, the Newcastle Disease Vaccine is forecast to a readjusted size of US$ 389.8 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Newcastle Disease Vaccine market. Newcastle Disease Vaccine are expected to show stable growth in the future m......
  • Global Classical Swine Fever Vaccines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 126
    According to our LPI (LP Information) latest study, the global Classical Swine Fever Vaccines market size was valued at US$ 151.4 million in 2023. With growing demand in downstream market, the Classical Swine Fever Vaccines is forecast to a readjusted size of US$ 209.8 million by 2030 with a CAGR of 4.8% during review period. The research report highlights the growth potential of the global Classical Swine Fever Vaccines market. Classical Swine Fever Vaccines are expected to show stable ......
  • Global Veterinary Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 151
    According to our LPI (LP Information) latest study, the global Veterinary Vaccine market size was valued at US$ 10570 million in 2023. With growing demand in downstream market, the Veterinary Vaccine is forecast to a readjusted size of US$ 17200 million by 2030 with a CAGR of 7.2% during review period. The research report highlights the growth potential of the global Veterinary Vaccine market. Veterinary Vaccine are expected to show stable growth in the future market. However, product di......
  • Global Foot and Mouth Disease (FMD) Vaccines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134
    According to our LPI (LP Information) latest study, the global Foot and Mouth Disease (FMD) Vaccines market size was valued at US$ 895.6 million in 2023. With growing demand in downstream market, the Foot and Mouth Disease (FMD) Vaccines is forecast to a readjusted size of US$ 1644.2 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Foot and Mouth Disease (FMD) Vaccines market. Foot and Mouth Disease (FMD) Vaccines......
  • Global Veterinary Products for Companion Animals Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Veterinary Products for Companion Animals market size was valued at US$ 15190 million in 2023. With growing demand in downstream market, the Veterinary Products for Companion Animals is forecast to a readjusted size of US$ 22710 million by 2030 with a CAGR of 5.9% during review period. The research report highlights the growth potential of the global Veterinary Products for Companion Animals market. Veterinary Products for Co......
  • Global Newcastle Disease Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 115
    According to our (Global Info Research) latest study, the global Newcastle Disease Vaccine market size was valued at USD 323.9 million in 2023 and is forecast to a readjusted size of USD 402.7 million by 2030 with a CAGR of 3.2% during review period. Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans. Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines s......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs